|
1
|
Branda F, Scarpa F, Romano C, Ciccozzi A, Maruotti A, Giovanetti M, Ciccozzi M. Chikungunya vaccine: Is it time for it? J Med Virol 2023; 95:e29341. [PMID: 38124664 DOI: 10.1002/jmv.29341] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2023] [Revised: 12/10/2023] [Accepted: 12/11/2023] [Indexed: 12/23/2023]
Affiliation(s)
- Francesco Branda
- Unit of Medical Statistics and Molecular Epidemiology, Università Campus Bio-Medico di Roma, Rome, Italy
| | - Fabio Scarpa
- Department of Biomedical Sciences, University of Sassari, Sassari, Italy
| | - Chiara Romano
- Unit of Medical Statistics and Molecular Epidemiology, Università Campus Bio-Medico di Roma, Rome, Italy
| | - Alessandra Ciccozzi
- Sciences and Technologies for Sustainable Development and One Health, Università Campus Bio-Medico di Roma, Rome, Italy
| | | | - Marta Giovanetti
- Sciences and Technologies for Sustainable Development and One Health, Università Campus Bio-Medico di Roma, Rome, Italy
- Instituto Rene Rachou, Fundação Oswaldo Cruz, Belo Horizonte, Minas Gerais, Brazil
- Climate Amplified Diseases and Epidemics (CLIMADE), Americas, Brazil
| | - Massimo Ciccozzi
- Unit of Medical Statistics and Molecular Epidemiology, Università Campus Bio-Medico di Roma, Rome, Italy
| |
Collapse
|
|
2
|
Alexiev I, Ivanov I, Giovanetti M, Cella E, Stoikov I, Donchev D, Grigorova L, Gancheva A, Dimitrova R, Scarpa F, Korsun N, Trifonova I, Dobrinov V, Kantardjiev T, Christova I, Ciccozzi M. Early Detection of the Recombinant SARS-CoV-2 XAN Variant in Bulgaria: Initial Genomic Insights into Yet Another Piece of the Growing Puzzle of Recombinant Clades. Microorganisms 2023; 11:2041. [PMID: 37630601 PMCID: PMC10457977 DOI: 10.3390/microorganisms11082041] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2023] [Revised: 07/29/2023] [Accepted: 08/07/2023] [Indexed: 08/27/2023] Open
Abstract
The first recombinant SARS-CoV-2 variants were identified in 2022, causing public health concerns. The importance of recombinant variants has increased especially since the WHO designated the recombinant variant XBB and its lineages as subvariants that require monitoring on 20 November 2022. In this study, we provide the first insights into the new SARS-CoV-2 variant named XAN, a recombinant composed of Omicron sub-lineages BA.2 and BA.5. To our knowledge, this is the first report on the recombinant SARS-CoV-2 XAN variant identified in Bulgaria.
Collapse
Affiliation(s)
- Ivailo Alexiev
- National Center of Infectious and Parasitic Diseases, 1504 Sofia, Bulgaria; (I.I.); (I.S.); (D.D.); (L.G.); (A.G.); (R.D.); (N.K.); (I.T.); (V.D.); (T.K.); (I.C.)
| | - Ivan Ivanov
- National Center of Infectious and Parasitic Diseases, 1504 Sofia, Bulgaria; (I.I.); (I.S.); (D.D.); (L.G.); (A.G.); (R.D.); (N.K.); (I.T.); (V.D.); (T.K.); (I.C.)
| | - Marta Giovanetti
- Instituto Rene Rachou Fundação Oswaldo Cruz, Belo Horizonte 30190-009, Minas Gerais, Brazil;
- Sciences and Technologies for Sustainable Development and One Health, Università Campus Bio-Medico di Roma, 00128 Rome, Italy
| | - Eleonora Cella
- Burnett School of Biomedical Sciences, University of Central Florida, Orlando, FL 32816, USA;
| | - Ivan Stoikov
- National Center of Infectious and Parasitic Diseases, 1504 Sofia, Bulgaria; (I.I.); (I.S.); (D.D.); (L.G.); (A.G.); (R.D.); (N.K.); (I.T.); (V.D.); (T.K.); (I.C.)
| | - Deyan Donchev
- National Center of Infectious and Parasitic Diseases, 1504 Sofia, Bulgaria; (I.I.); (I.S.); (D.D.); (L.G.); (A.G.); (R.D.); (N.K.); (I.T.); (V.D.); (T.K.); (I.C.)
| | - Lyubomira Grigorova
- National Center of Infectious and Parasitic Diseases, 1504 Sofia, Bulgaria; (I.I.); (I.S.); (D.D.); (L.G.); (A.G.); (R.D.); (N.K.); (I.T.); (V.D.); (T.K.); (I.C.)
| | - Anna Gancheva
- National Center of Infectious and Parasitic Diseases, 1504 Sofia, Bulgaria; (I.I.); (I.S.); (D.D.); (L.G.); (A.G.); (R.D.); (N.K.); (I.T.); (V.D.); (T.K.); (I.C.)
| | - Reneta Dimitrova
- National Center of Infectious and Parasitic Diseases, 1504 Sofia, Bulgaria; (I.I.); (I.S.); (D.D.); (L.G.); (A.G.); (R.D.); (N.K.); (I.T.); (V.D.); (T.K.); (I.C.)
| | - Fabio Scarpa
- Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy
| | - Neli Korsun
- National Center of Infectious and Parasitic Diseases, 1504 Sofia, Bulgaria; (I.I.); (I.S.); (D.D.); (L.G.); (A.G.); (R.D.); (N.K.); (I.T.); (V.D.); (T.K.); (I.C.)
| | - Ivelina Trifonova
- National Center of Infectious and Parasitic Diseases, 1504 Sofia, Bulgaria; (I.I.); (I.S.); (D.D.); (L.G.); (A.G.); (R.D.); (N.K.); (I.T.); (V.D.); (T.K.); (I.C.)
| | - Veselin Dobrinov
- National Center of Infectious and Parasitic Diseases, 1504 Sofia, Bulgaria; (I.I.); (I.S.); (D.D.); (L.G.); (A.G.); (R.D.); (N.K.); (I.T.); (V.D.); (T.K.); (I.C.)
| | - Todor Kantardjiev
- National Center of Infectious and Parasitic Diseases, 1504 Sofia, Bulgaria; (I.I.); (I.S.); (D.D.); (L.G.); (A.G.); (R.D.); (N.K.); (I.T.); (V.D.); (T.K.); (I.C.)
| | - Iva Christova
- National Center of Infectious and Parasitic Diseases, 1504 Sofia, Bulgaria; (I.I.); (I.S.); (D.D.); (L.G.); (A.G.); (R.D.); (N.K.); (I.T.); (V.D.); (T.K.); (I.C.)
| | - Massimo Ciccozzi
- Unit of Medical Statistics and Molecular Epidemiology, Università Campus Bio-Medico di Roma, 00128 Rome, Italy;
| |
Collapse
|
|
3
|
Formichi C, Nigi L, Grieco GE, Maccora C, Fignani D, Brusco N, Licata G, Sebastiani G, Dotta F. Non-Coding RNAs: Novel Players in Insulin Resistance and Related Diseases. Int J Mol Sci 2021; 22:7716. [PMID: 34299336 PMCID: PMC8306942 DOI: 10.3390/ijms22147716] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2021] [Revised: 07/13/2021] [Accepted: 07/15/2021] [Indexed: 12/12/2022] Open
Abstract
The rising prevalence of metabolic diseases related to insulin resistance (IR) have stressed the urgent need of accurate and applicable tools for early diagnosis and treatment. In the last decade, non-coding RNAs (ncRNAs) have gained growing interest because of their potential role in IR modulation. NcRNAs are variable-length transcripts which are not translated into proteins but are involved in gene expression regulation. Thanks to their stability and easy detection in biological fluids, ncRNAs have been investigated as promising diagnostic and therapeutic markers in metabolic diseases, such as type 2 diabetes mellitus (T2D), obesity and non-alcoholic fatty liver disease (NAFLD). Here we review the emerging role of ncRNAs in the development of IR and related diseases such as obesity, T2D and NAFLD, and summarize current evidence concerning their potential clinical application.
Collapse
Affiliation(s)
- Caterina Formichi
- Diabetes Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, 53100 Siena, Italy; (C.F.); (L.N.); (G.E.G.); (D.F.); (N.B.); (G.L.); (G.S.)
- Fondazione Umberto Di Mario, c/o Toscana Life Sciences, 53100 Siena, Italy
| | - Laura Nigi
- Diabetes Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, 53100 Siena, Italy; (C.F.); (L.N.); (G.E.G.); (D.F.); (N.B.); (G.L.); (G.S.)
- Fondazione Umberto Di Mario, c/o Toscana Life Sciences, 53100 Siena, Italy
| | - Giuseppina Emanuela Grieco
- Diabetes Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, 53100 Siena, Italy; (C.F.); (L.N.); (G.E.G.); (D.F.); (N.B.); (G.L.); (G.S.)
- Fondazione Umberto Di Mario, c/o Toscana Life Sciences, 53100 Siena, Italy
| | - Carla Maccora
- Section of Medical Pathophysiology, Food Science and Endocrinology, Department of Experimental Medicine, Sapienza University, 00185 Rome, Italy;
| | - Daniela Fignani
- Diabetes Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, 53100 Siena, Italy; (C.F.); (L.N.); (G.E.G.); (D.F.); (N.B.); (G.L.); (G.S.)
- Fondazione Umberto Di Mario, c/o Toscana Life Sciences, 53100 Siena, Italy
| | - Noemi Brusco
- Diabetes Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, 53100 Siena, Italy; (C.F.); (L.N.); (G.E.G.); (D.F.); (N.B.); (G.L.); (G.S.)
- Fondazione Umberto Di Mario, c/o Toscana Life Sciences, 53100 Siena, Italy
| | - Giada Licata
- Diabetes Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, 53100 Siena, Italy; (C.F.); (L.N.); (G.E.G.); (D.F.); (N.B.); (G.L.); (G.S.)
- Fondazione Umberto Di Mario, c/o Toscana Life Sciences, 53100 Siena, Italy
| | - Guido Sebastiani
- Diabetes Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, 53100 Siena, Italy; (C.F.); (L.N.); (G.E.G.); (D.F.); (N.B.); (G.L.); (G.S.)
- Fondazione Umberto Di Mario, c/o Toscana Life Sciences, 53100 Siena, Italy
| | - Francesco Dotta
- Diabetes Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, 53100 Siena, Italy; (C.F.); (L.N.); (G.E.G.); (D.F.); (N.B.); (G.L.); (G.S.)
- Fondazione Umberto Di Mario, c/o Toscana Life Sciences, 53100 Siena, Italy
- Tuscany Centre for Precision Medicine (CReMeP), 53100 Siena, Italy
| |
Collapse
|